Cite
HARVARD Citation
Hellings, P. et al. (2015). A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Clinical and translational allergy. 5 (4), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hellings, P. et al. (2015). A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Clinical and translational allergy. 5 (4), p. 1. [Online].